Search - tctmd.com

Displaying 841 - 860 of 2954

Sort: Relevancy | Date

News Conference News TCT 2018

ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year

Lucy Hicks

September 24, 2018

Presentation TCT 2018

Is Multivessel Revascularization During Primary PCI in STEMI Necessary, Desirable, or Contraindicated?

Presenter: Michael Kang-Yin Lee, Ivo Petrov, Marin Postu, Zoltan Ruzsa, Stefan Mot

September 24, 2018

News Conference News TCT 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

Todd Neale

September 24, 2018

Presentation TCT 2018

Case #8: Severe Obstructive HCM in a Symptomatic Patient Despite Maximized Medical Therapy and Septal Thickness of 13 mm.

Presenter: Sherif F. Nagueh, Hubert Seggewiss, John S. Douglas Jr, Valerian Fernandes, Vijay Iyer, Srihari S. Naidu, Nish Patel, Alexandre C. Zago

September 24, 2018

Presentation TCT 2018

A Patient With Atrial Fibrillation, Cryptogenic Stroke, and PFO: Watchman Despite OAC?

Presenter: Zahid Amin, Robert J. Sommer, Peter C. Block, John P. Breinholt, Craig E Fleishman, Jan Kovac, Harsimran Sachdeva Singh, Christian Spies

September 24, 2018

Presentation TCT 2018

MAIN-COMPARE: Ten-Year Follow-up From a Nonrandomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main Disease

Presenter: Jeroen J. Bax, Seung-Jung Park

September 24, 2018

Presentation TCT 2018

SYNTAXES: Ten-Year Follow-up From a Randomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main and Triple Vessel Disease (Preliminary Results)

Presenter: Jeroen J. Bax, Daniel J.F.M. Thuijs

September 24, 2018

Presentation TCT 2018

Case #1: Severe LVOT Obstruction in a Symptomatic 20-Year Old Male Despite Maximized Medical Treatment

Presenter: Sherif F. Nagueh, Hubert Seggewiss, John S. Douglas Jr, Valerian Fernandes, Vijay Iyer, Srihari S. Naidu, Nish Patel, Alexandre C. Zago

September 24, 2018

Presentation TCT 2018

PREPARE-CALC: A Randomized Trial of High-speed Rotational Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions

Presenter: Jeroen J. Bax, Gert Richardt

September 24, 2018

Presentation TCT 2018

Addressing the Hurdles: Emerging Devices and Novel Valve Designs

Presenter: Howard C. Herrmann, Vinod H. Thourani

September 24, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Three: Intravascular Imaging and Anticoagulation

Shelley Wood

September 24, 2018

Presentation TCT 2018

The LAMPOON Procedure: Description and Clinical Outcomes

Presenter: James B. Hermiller Jr, Wilson Y. Szeto, Robert J. Lederman

September 24, 2018

Presentation TCT 2018

Case Presentation: Deterioration of LV Systolic Function/Worsened Heart Failure Despite Successful TMVR

Presenter: James B. Hermiller Jr, Wilson Y. Szeto, Khalil Fattouch, Sameer Gafoor, Adam B. Greenbaum, Roger J. Laham, Ruediger S. Lange, Rashmi Yadav

September 24, 2018

Presentation TCT 2018

ULTIMATE: A Randomized Trial of Intravascular Ultrasound Guidance of Coronary Drug-Eluting Stent Implantation in an All-Comers Patient Population

Presenter: Gregg W. Stone, Junjie Zhang

September 24, 2018

Presentation TCT 2018

Tendyne: Device Attributes, Implant Procedure, Clinical Results and SUMMIT Design and Status

Presenter: Michael J. Mack, David W.M. Muller, Gorav Ailawadi

September 24, 2018

Presentation TCT 2018

Intrepid: Device Attributes, Implant Procedure, Clinical Results, and APOLLO Design and Status

Presenter: Michael J. Mack, David W.M. Muller, Michael J. Reardon

September 24, 2018

News Conference News TCT 2018

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

Todd Neale

September 24, 2018

Presentation TCT 2018

Should and Will COAPT Affect TMVR Trial Design and Patient Recruitment?

Presenter: David H. Adams, Shmuel Banai, Michael J. Mack

September 24, 2018

Presentation TCT 2018

Transcatheter Repair or Replacement for Secondary MR? Risk-Benefit Analysis

Presenter: David H. Adams, Shmuel Banai, Jason H. Rogers

September 24, 2018

Presentation TCT 2018

Adverse Outcomes in Early Feasibility TMVR Studies: Is it the Patient, the Device, or the Implant Technique?

Presenter: David H. Adams, Shmuel Banai, Molly Szerlip

September 24, 2018

Advertisement

ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year

Is Multivessel Revascularization During Primary PCI in STEMI Necessary, Desirable, or Contraindicated?

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

Case #8: Severe Obstructive HCM in a Symptomatic Patient Despite Maximized Medical Therapy and Septal Thickness of 13 mm.

A Patient With Atrial Fibrillation, Cryptogenic Stroke, and PFO: Watchman Despite OAC?

MAIN-COMPARE: Ten-Year Follow-up From a Nonrandomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main Disease

SYNTAXES: Ten-Year Follow-up From a Randomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main and Triple Vessel Disease (Preliminary Results)

Case #1: Severe LVOT Obstruction in a Symptomatic 20-Year Old Male Despite Maximized Medical Treatment

PREPARE-CALC: A Randomized Trial of High-speed Rotational Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions

Addressing the Hurdles: Emerging Devices and Novel Valve Designs

TCT 2018, Day Three: Intravascular Imaging and Anticoagulation

The LAMPOON Procedure: Description and Clinical Outcomes

Case Presentation: Deterioration of LV Systolic Function/Worsened Heart Failure Despite Successful TMVR

ULTIMATE: A Randomized Trial of Intravascular Ultrasound Guidance of Coronary Drug-Eluting Stent Implantation in an All-Comers Patient Population

Tendyne: Device Attributes, Implant Procedure, Clinical Results and SUMMIT Design and Status

Intrepid: Device Attributes, Implant Procedure, Clinical Results, and APOLLO Design and Status

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

Should and Will COAPT Affect TMVR Trial Design and Patient Recruitment?

Transcatheter Repair or Replacement for Secondary MR? Risk-Benefit Analysis

Adverse Outcomes in Early Feasibility TMVR Studies: Is it the Patient, the Device, or the Implant Technique?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content